Efficacy of Donepezil in the posterior variant of Alzheimers disease (Posterior Cortical Atrophy) Study.
Phase of Trial: Phase II
Latest Information Update: 21 Apr 2017
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Acronyms DONIPAD
- 05 Jan 2012 Actual end date 30 Jun 2011 added as reported by UKCRN.
- 05 Jan 2012 Status changed from active, no longer recruiting to completed as reported by UKCRN.
- 06 Jul 2011 United Kingdom Clinical Research Network reports accrual to date changed from 85% to 90%.